We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.02%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.99B
AUM Growth
+$445M
Cap. Flow
-$204M
Cap. Flow %
-5.12%
Top 10 Hldgs %
26.88%
Holding
133
New
39
Increased
28
Reduced
23
Closed
37

Top Sells

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$86.2M
2
CI icon
Cigna
CI
+$69.3M
3
CRM icon
Salesforce
CRM
+$63M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$61.7M
5
BIIB icon
Biogen
BIIB
+$55.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.53%
2 Technology 10.63%
3 Communication Services 6.21%
4 Energy 4.56%
5 Consumer Discretionary 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNCE
76
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$11M 0.27%
+498,714
New +$10.6M
NVRO
77
DELISTED
NEVRO CORP.
NVRO
$10.9M 0.27%
+116,836
New +$10.6M
EVH icon
78
Evolent Health
EVH
$429M
$10.7M 0.27%
+480,422
New +$9.22M
STX icon
79
Seagate
STX
$185B
$10.7M 0.27%
+232,051
New +$10.3M
WERN icon
80
Werner Enterprises
WERN
$2.42B
$9.91M 0.25%
378,393
+189,035
+100% +$5.15M
COLL icon
81
Collegium Pharmaceutical
COLL
$1.15B
$7.99M 0.2%
794,550
-623,591
-44% -$9.27M
TEX icon
82
Terex
TEX
$7.89B
$5.51M 0.14%
175,632
-285,565
-62% -$8.97M
SAGE
83
DELISTED
Sage Therapeutics
SAGE
$5.34M 0.13%
+75,158
New +$4.4M
AVXS
84
DELISTED
AveXis, Inc. Common Stock
AVXS
$5.33M 0.13%
+70,170
New +$4.34M
INGN icon
85
Inogen
INGN
$171M
$4.8M 0.12%
+61,951
New +$4.29M
MT icon
86
ArcelorMittal
MT
$50.9B
$4.6M 0.12%
+183,797
New +$4.65M
IVTY
87
DELISTED
Invuity, Inc
IVTY
$3.42M 0.09%
429,891
+198,562
+86% +$1.45M
JUNO
88
DELISTED
Juno Therapeutics, Inc.
JUNO
$2.54M 0.06%
114,695
-4,973
-4% -$107K
XENT
89
DELISTED
Intersect ENT, Inc
XENT
$2.39M 0.06%
+139,611
New +$1.96M
ZLTQ
90
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$115K ﹤0.01%
2,062
-368,999
-99% -$18.5M
AMAT icon
91
Applied Materials
AMAT
$410B
-617,952
Closed -$19.9M
BAC icon
92
Bank of America
BAC
$436B
-467,862
Closed -$10.3M
CME icon
93
CME Group
CME
$91.8B
-129,540
Closed -$14.9M
CRM icon
94
Salesforce
CRM
$142B
-920,244
Closed -$63M
DTD icon
95
CALL
WisdomTree US Total Dividend Fund
DTD
$1.65B
-5,461,800
Closed -$135M
DVN icon
96
Devon Energy
DVN
$49.8B
-592,379
Closed -$27.1M
DXJ icon
97
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
-599,921
Closed -$29.7M
DY icon
98
Dycom Industries
DY
$12.7B
-66,976
Closed -$5.38M
GOOGL icon
99
Alphabet (Google) Class A
GOOGL
$3.99T
-1,028,860
Closed -$40.8M
HON icon
100
Honeywell
HON
$77.9B
-198,805
Closed -$20.8M

Similar funds

PFM Health Sciences's Q1 2017 Portfolio in Review

As of Q1 2017, PFM Health Sciences held 133 positions worth $3.99B, up 13% from $3.55B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $204M in Q1 2017, closing 37 positions and reducing 23 holdings. Its most notable exit was Range Resources, an estimated $86.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Liberty Global Class A worth $111M.

  • PFM Health Sciences's largest Q1 2017 buy was Liberty Global Class A: 3,089,161 shares worth $111M.
  • PFM Health Sciences added most to Marvell Technology in Q1 2017, an estimated $99.1M increase.
  • PFM Health Sciences's biggest Q1 2017 reduction was Cigna, cutting an estimated $69.3M.
  • PFM Health Sciences fully exited Range Resources in Q1 2017, selling an estimated $86.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $3.99B portfolio in Q1 2017.
  • PFM Health Sciences opened 39 new positions and closed 37 in Q1 2017.
  • PFM Health Sciences's portfolio value rose 13% quarter-over-quarter to $3.99B.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.